AstraZeneca Pharma India Limited (BOM:506820)

AstraZeneca Pharma India Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 20, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	222,408	215,159	133,010	81,183	63,886	75,255
Market Cap Growth	61.76%	61.76%	63.84%	27.07%	-15.11%	25.87%
Enterprise Value	217,398	210,362	127,861	76,552	60,484	72,857
Last Close Price	8896.30	8606.35	5302.47	3222.61	2529.13	2977.28
PE Ratio	192.14	185.90	82.35	81.76	103.71	80.66
PS Ratio	12.96	12.54	10.27	8.09	7.93	9.25
PB Ratio	28.87	27.93	18.68	13.79	12.49	16.50
P/TBV Ratio	28.90	27.95	18.74	13.79	12.49	16.50
P/FCF Ratio	349.64	338.25	777.38	163.12	70.07	77.53
P/OCF Ratio	340.28	329.19	477.25	139.27	63.38	71.82
EV/Sales Ratio	12.67	12.26	9.87	7.63	7.51	8.96
EV/EBITDA Ratio	85.60	82.83	69.81	47.45	73.16	54.94
EV/EBIT Ratio	101.60	98.31	74.58	51.43	87.20	62.67
EV/FCF Ratio	341.77	330.71	747.29	153.81	66.33	75.06
Debt / Equity Ratio	0.05	0.05	0.01	0.01	0.02	0.03
Debt / EBITDA Ratio	0.14	0.14	0.02	0.04	0.10	0.09
Debt / FCF Ratio	0.56	0.56	0.27	0.14	0.10	0.13
Asset Turnover	1.32	1.32	1.26	1.09	0.99	1.10
Inventory Turnover	2.48	2.48	2.87	2.22	2.11	1.85
Quick Ratio	1.03	1.03	1.89	1.61	1.64	1.46
Current Ratio	1.91	1.91	2.61	2.18	2.12	2.04
Return on Equity (ROE)	15.62%	15.62%	24.84%	18.05%	12.73%	22.74%
Return on Assets (ROA)	10.30%	10.30%	10.39%	10.11%	5.32%	9.81%
Return on Capital (ROIC)	17.57%	17.57%	16.33%	16.67%	8.77%	17.21%
Return on Capital Employed (ROCE)	26.30%	26.30%	23.80%	24.80%	13.20%	24.70%
Earnings Yield	0.52%	0.54%	1.21%	1.22%	0.96%	1.24%
FCF Yield	0.29%	0.30%	0.13%	0.61%	1.43%	1.29%
Dividend Yield	0.36%	0.37%	0.45%	0.50%	0.40%	0.07%
Payout Ratio	51.84%	51.84%	24.77%	20.14%	8.12%	5.36%
Buyback Yield / Dilution	0.01%	0.01%	-	-	-	-
Total Shareholder Return	0.33%	0.38%	0.45%	0.50%	0.40%	0.07%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.